Skip to main content
. 2019 Oct 15;93(21):e02041-18. doi: 10.1128/JVI.02041-18

FIG 3.

FIG 3

FCGR3B-AGA haplotype modified immune correlates of risk in HVTN 505. (A) Distributions of Env-specific IgG responses, as assessed by binding antibody multiplex assay, plotted according to case/control HIV infection outcome status and FCGR3B-AGA haplotype status. (B) Distributions of Env-specific CD8 polyfunctionality scores (PFS), plotted according to case/control status and FCGR3B-AGA haplotype status. (C) Percentages of HVTN 505 vaccine recipients having medium or high responses for either Env IgG or CD8 PFS in HVTN 505 cases and controls, plotted according to case/control status and FCGR3B-AGA haplotype status.